| 臺大學術典藏 |
2021-07-03T03:35:40Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng A.-L.; Hsiung C.A.; Su I.-J.; PEI-JER CHEN; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-07-03T03:35:21Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:28Z |
Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside - The Taiwan experience
|
YAO-CHANG CHEN; Lin S.-F.; Yao M.; Chen T.-Y.; Tsao C.-J.; Chen T.-P. |
| 臺大學術典藏 |
2021-01-05T03:35:02Z |
Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside - The Taiwan experience
|
Chen T.-P.; Tsao C.-J.; Chen T.-Y.; MING YAO; Lin S.-F.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:01Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Whang-Peng J.; Chen L.-T.; HWEI-FANG TIEN; Chao T.-Y.; Hsu C.-H.; Uen W.-C.; Kao W.-Y.; Tsao C.-J.; Chang M.-C.; Chen P.-J.; Su I.-J.; Cheng A.-L.; Hsiung C.A. |
| 國立成功大學 |
2021 |
Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer
|
Wu, H.-C.;Lin, W.-L.;Lin, C.-L.;Lin, C.-Y.;Chen, S.-W.;Chen, Y.-X.;Chen, Chen C.-H.;Lee, S.-W.;Chen, S.-H.;Tsao, C.-J.;Huang, W.-T.;Guo, H.-R. |
| 國立成功大學 |
2021 |
Colorectal Cancer with EML4-ALK Fusion Gene Response to Alectinib: A Case Report and Review of the Literature
|
Hsiao, S.-Y.;He, He H.-L.;Weng, T.-S.;Lin, C.-Y.;Chao, Chao C.-M.;Huang, W.-T.;Tsao, C.-J. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study
|
Botwood N; Thatcher N.; Watkins C; Tsao C.-J; CHIH-HSIN YANG; Ganzon D; Perng R.-P; Tan E.H; Thongprasert S; Parikh P; Chang A; Chang A;Parikh P;Thongprasert S;Tan E.H;Perng R.-P;Ganzon D;Chih-Hsin Yang;Tsao C.-J;Watkins C;Botwood N;Thatcher N. |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y. |
| 臺大學術典藏 |
2020-05-25T07:35:27Z |
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
|
Abou-Alfa G.K; Chan S.L; Chia-Chi Lin; Chiorean E.G; Holcombe R.F; Mulcahy M.F; Carter W.D; Patel K; Wilson W.R; Melink T.J; Gutheil J.C; Tsao C.-J. |
